A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge

BACKGROUND: Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory disease in humans, with a case fatality rate of approximately 35%, thus posing a considerable threat to public health. The lack of approved vaccines or antivirals currently constitutes a barrier in controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jung-Eun, Kim, Ji-Hee, Park, Jae-Yeon, Jun, Sung-Hoon, Shin, Hyun-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235161/
https://www.ncbi.nlm.nih.gov/pubmed/35761402
http://dx.doi.org/10.1186/s12985-022-01844-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235161/
https://www.ncbi.nlm.nih.gov/pubmed/35761402
http://dx.doi.org/10.1186/s12985-022-01844-9

Ejemplares similares